|
|
|
|
| LEADER |
05552nam a2200649 4500 |
| 001 |
ocn894792339 |
| 003 |
OCoLC |
| 005 |
20170124071721.4 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
141108s2014 xx o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d DG1
|d OCLCF
|d YDXCP
|d DEBBG
|d OCLCQ
|d OCLCO
|d GrThAP
|
| 019 |
|
|
|a 899273571
|
| 020 |
|
|
|a 9781118504499
|q (electronic bk.)
|
| 020 |
|
|
|a 1118504496
|q (electronic bk.)
|
| 020 |
|
|
|z 9781118504512
|
| 020 |
|
|
|z 1118504518
|
| 020 |
|
|
|z 9780470672020
|
| 020 |
|
|
|z 0470672021
|
| 029 |
1 |
|
|a DEBBG
|b BV043397275
|
| 029 |
1 |
|
|a NZ1
|b 15913273
|
| 035 |
|
|
|a (OCoLC)894792339
|z (OCoLC)899273571
|
| 050 |
|
4 |
|a RC86.8
|
| 082 |
0 |
4 |
|a 616.02
|a 616.028
|
| 049 |
|
|
|a MAIN
|
| 100 |
1 |
|
|a Kipshidze, Nicholas.
|
| 245 |
1 |
0 |
|a Urgent Interventional Therapies.
|
| 264 |
|
1 |
|a Hoboken :
|b Wiley,
|c 2014.
|
| 300 |
|
|
|a 1 online resource (595 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Urgent Interventional Therapies; Copyright; Contents; List of Contributors; Foreword; Preface; List of Abbreviations; About the Companion Website; Part 1 Cardiac Interventions; Section I: Acute Coronary Syndrome; Chapter 1 Acute Coronary Syndrome: Guidelines and Definitions; Introduction; Definitions; Pathophysiology; Therapeutic strategies; Other considerations; References; Chapter 2 Cardiac Biomarkers in Acute Cardiac Care; Introduction; Markers of endothelial dysfunction; Biomarkers of vascular inflammation; Biomarkers of myocardial ischemia; Biomarkers of plaque destabilization.
|
| 505 |
8 |
|
|a Biomarkers of plaque ruptureBiomarkers of myocardial injury; Biomarkers of myocardial stretch or dysfunction; Summary; References; Chapter 3 Diagnosis of Vulnerable Plaque; Introduction; Coronary angiography; Intravascular ultrasound; Coronary angioscopy; Near-infared spectroscopy; Optical coherence tomography; Intravascular thermography; Interventional treatment of vulnerable plaques; Conclusion; Summary; References; Chapter 4 Management of Thrombotic Disorders: Heparin to Newer Anticoagulants; Introduction and overview; Low molecular weight heparins; Ultra-low molecular weight heparins.
|
| 505 |
8 |
|
|a Antithrombin agentsFactor Xa inhibitors; Generic antithrombotic drugs; Newer oral anticoagulants versus heparins; Some unanswered questions regarding the new oral anticoagulants; Summary; Future perspectives; References; Chapter 5 Newer Antiplatelet Agents for Interventional Indications; Introduction; Clopidogrel; Prasugrel; Ticagrelor; Conclusion; References; Chapter 6 Genetic Considerations of Antiplatelet Therapy; Introduction; General considerations; Specific genetic considerations; Therapeutic strategies; Practical recommendations; References.
|
| 505 |
8 |
|
|a Chapter 7 Anticoagulant Management of Heparin-Compromised PatientsIntroduction; Heparin; Anticoagulant alternatives to heparin; Summary; References; Chapter 8 Management of Bleeding in Urgent Interventions; Introduction; Incidence of bleeding; Risks associated with increased bleeding; Long-term outcomes; Mechanical and other contributors to bleeding; Measures to reduce the incidence of bleeding; Treatment of bleeding; New potential agents for the reversal of anticoagulation; References; Chapter 9 Role of Newer Anti-Xa and Anti-IIa Agents for Interventions; Introduction.
|
| 505 |
8 |
|
|a Percutaneous coronary interventionNew anti-IIa and anti-Xa agents; New anticoagulants for cardiac interventional procedures; Conclusion; Summary; References; Chapter 10 Treatment of NSTEMI Patients; Introduction; Presentation and diagnosis; Antiplatelet therapies; Anticoagulation strategies; Invasive versus medical therapy; Conclusion; References; Chapter 11 Treatment of Patients with STEMI; Introduction; Indication; Literature review; Invasive treatment center; Technique of primary PCI; Summary; References.
|
| 500 |
|
|
|a Chapter 12 Mechanical Removal of Thrombus from Culprit Lesions: Current Devices and Future Developments.
|
| 520 |
|
|
|a Illustrating the differences between urgent interventions and interventions performed to manage chronic conditions the authors present the chapters in a consistent template for ease of use covering; background, indications, evidence review, device description, procedural techniques, follow-up care, and complications. Shows the differences between interventions performed to manage chronic conditions and interventions that are truly urgentChapters follow a consistent structure from background through indications, evidence review, device description, procedural techniques to follow-up care and c.
|
| 650 |
|
0 |
|a Cardiovascular emergencies.
|
| 650 |
|
0 |
|a Critical care medicine.
|
| 650 |
|
0 |
|a Medical emergencies.
|
| 650 |
|
4 |
|a Cardiovascular diseases
|x Therapy.
|
| 650 |
|
4 |
|a Critical care
|x Methods.
|
| 650 |
|
4 |
|a Emergencies.
|
| 650 |
|
4 |
|a Emergency treatment
|x Methods.
|
| 650 |
|
7 |
|a Cardiovascular emergencies.
|2 fast
|0 (OCoLC)fst00847162
|
| 650 |
|
7 |
|a Critical care medicine.
|2 fast
|0 (OCoLC)fst00883647
|
| 650 |
|
7 |
|a Medical emergencies.
|2 fast
|0 (OCoLC)fst01014070
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Fareed, Jawed.
|
| 700 |
1 |
|
|a Rosen, Robert T.
|
| 700 |
1 |
|
|a Serruys, Patrick.
|
| 776 |
0 |
8 |
|i Print version:
|a Kipshidze, Nicholas.
|t Urgent Interventional Therapies.
|d Hoboken : Wiley, ©2014
|z 9780470672020
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781118504499
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
